Breast cancer and hormonal supplements in postmenopausal women.
作者信息
McPherson K
出版信息
BMJ. 1995 Sep 16;311(7007):699-700. doi: 10.1136/bmj.311.7007.699.
Abstract
摘要
相似文献
1
Breast cancer and hormonal supplements in postmenopausal women.绝经后女性的乳腺癌与激素补充剂
BMJ. 1995 Sep 16;311(7007):699-700. doi: 10.1136/bmj.311.7007.699.
2
Breast cancer and hormonal supplements in postmenopausal women. Increase in risk of breast cancer is small.绝经后女性的乳腺癌与激素补充剂。乳腺癌风险的增加幅度较小。
BMJ. 1995 Dec 2;311(7018):1505. doi: 10.1136/bmj.311.7018.1505a.
3
Breast cancer and hormonal supplements in postmenopausal women. Benefits probably outweight risks.绝经后女性的乳腺癌与激素补充剂。益处可能超过风险。
BMJ. 1995 Dec 2;311(7018):1504-5.
4
Breast cancer and hormonal supplements in postmenopausal women. Article increased uncertainty.绝经后女性的乳腺癌与激素补充剂。文章增加了不确定性。
BMJ. 1995 Dec 2;311(7018):1505. doi: 10.1136/bmj.311.7018.1505b.
5
Prospective study of estrogen replacement therapy and risk of breast cancer in postmenopausal women.
JAMA. 1990 Nov 28;264(20):2648-53.
6
7
[Estrogen substitution following the menopause and the risk of breast cancer; the importance of endogenous risk factors].绝经后雌激素替代与乳腺癌风险；内源性危险因素的重要性
Ned Tijdschr Geneeskd. 1992 Jul 11;136(28):1337-9.
8
Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women.绝经后女性联合使用雌激素和睾酮与乳腺癌风险
Arch Intern Med. 2006 Jul 24;166(14):1483-9. doi: 10.1001/archinte.166.14.1483.
9
Hormonal treatment of postmenopausal women.绝经后女性的激素治疗。
N Engl J Med. 1994 Apr 14;330(15):1062-71. doi: 10.1056/NEJM199404143301508.
10
A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer.雌激素替代疗法对乳腺癌风险影响的荟萃分析。
JAMA. 1991 Apr 17;265(15):1985-90.
引用本文的文献
1
Why do women doctors in the UK take hormone replacement therapy?英国的女医生为何采用激素替代疗法？
J Epidemiol Community Health. 1997 Aug;51(4):373-7. doi: 10.1136/jech.51.4.373.
2
HRT and heart disease.激素替代疗法与心脏病
Postgrad Med J. 1997 Aug;73(862):465. doi: 10.1136/pgmj.73.862.465.
3
Prevention and management of osteoporosis. Current trends and future prospects.骨质疏松症的预防与管理。当前趋势及未来展望。
Drugs. 1997 May;53(5):727-35. doi: 10.2165/00003495-199753050-00001.
4
Use of hormone replacement therapy. Authors gave distorted view through selective citation.激素替代疗法的使用。作者通过选择性引用给出了扭曲的观点。
BMJ. 1996 Sep 14;313(7058):686-7. doi: 10.1136/bmj.313.7058.686b.
5
Oral contraceptives and breast cancer.口服避孕药与乳腺癌
BMJ. 1996 Jul 13;313(7049):63-4. doi: 10.1136/bmj.313.7049.63.
6
Women need to be fully informed about risks of hormone replacement therapy.需要让女性充分了解激素替代疗法的风险。
BMJ. 1996 May 18;312(7041):1301. doi: 10.1136/bmj.312.7041.1301.
7
Breast cancer and hormonal supplements in postmenopausal women. Increase in risk of breast cancer is small.绝经后女性的乳腺癌与激素补充剂。乳腺癌风险的增加幅度较小。
BMJ. 1995 Dec 2;311(7018):1505. doi: 10.1136/bmj.311.7018.1505a.
8
Breast cancer and hormonal supplements in postmenopausal women. Article increased uncertainty.绝经后女性的乳腺癌与激素补充剂。文章增加了不确定性。
BMJ. 1995 Dec 2;311(7018):1505. doi: 10.1136/bmj.311.7018.1505b.
9
Breast cancer and hormonal supplements in postmenopausal women. Benefits probably outweight risks.绝经后女性的乳腺癌与激素补充剂。益处可能超过风险。
BMJ. 1995 Dec 2;311(7018):1504-5.
本文引用的文献
1
Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study.对接受血管紧张素转换酶抑制剂治疗的慢性心力衰竭患者停用洋地黄。RADIANCE研究。
N Engl J Med. 1993 Jul 1;329(1):1-7. doi: 10.1056/NEJM199307013290101.
2
Hormone replacement therapy and risk of breast cancer: results from epidemiologic studies.激素替代疗法与乳腺癌风险：流行病学研究结果
Am J Obstet Gynecol. 1993 May;168(5):1473-80. doi: 10.1016/s0002-9378(11)90784-4.
3
Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk.雌激素、孕激素、正常乳腺细胞增殖与乳腺癌风险。
Epidemiol Rev. 1993;15(1):17-35. doi: 10.1093/oxfordjournals.epirev.a036102.
4
Measuring the impact of menopausal symptoms on quality of life.测量更年期症状对生活质量的影响。
BMJ. 1993 Oct 2;307(6908):836-40. doi: 10.1136/bmj.307.6908.836.
5
The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. The ATBC Cancer Prevention Study Group.α-生育酚、β-胡萝卜素肺癌预防研究：设计、方法、参与者特征及依从性。ATBC癌症预防研究组
Ann Epidemiol. 1994 Jan;4(1):1-10. doi: 10.1016/1047-2797(94)90036-1.
6
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.绝经后女性使用雌激素和孕激素与患乳腺癌风险
N Engl J Med. 1995 Jun 15;332(24):1589-93. doi: 10.1056/NEJM199506153322401.
7
Decreased incidence of breast cancer in postmenopausal estrogen-progestogen users.绝经后使用雌激素-孕激素者乳腺癌发病率降低。
Obstet Gynecol. 1983 Oct;62(4):435-43.
8
The risk of breast cancer after estrogen and estrogen-progestin replacement.雌激素及雌孕激素替代治疗后患乳腺癌的风险。
N Engl J Med. 1989 Aug 3;321(5):293-7. doi: 10.1056/NEJM198908033210505.
9
Complications of hormone replacement therapy in post-menopausal women.绝经后女性激素替代疗法的并发症
J R Soc Med. 1992 Jul;85(7):376-8.
10
Hormone therapy to prevent disease and prolong life in postmenopausal women.激素疗法用于预防绝经后女性疾病并延长寿命。
Ann Intern Med. 1992 Dec 15;117(12):1016-37. doi: 10.7326/0003-4819-117-12-1016.
Zotero 插件